| Stage | MAR | % of rev | PENN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.0B | 100.00% | $1.9B | 100.00% | MAR ×3.77 |
| Gross profit | $1.5B | 22.03% | $691M | 37.18% | PENN +15.1pp |
| Operating income | $1.3B | 18.19% | $132M | 7.09% | MAR +11.1pp |
| Pre-tax income | $1.1B | 15.13% | $40M | 2.14% | MAR +13.0pp |
| Net income | $794M | 11.33% | $33M | 1.76% | MAR +9.6pp |
| Stage | MAR | PENN | Gap · A − B |
|---|---|---|---|
| Revenue | $7.0B100.00% | $1.9B100.00% | MAR ×3.77 |
| Gross profit | 22.03%$1.5B | 37.18%$691M | PENN +15.1pp |
| Operating income | 18.19%$1.3B | 7.09%$132M | MAR +11.1pp |
| Pre-tax income | 15.13%$1.1B | 2.14%$40M | MAR +13.0pp |
| Net income |
| 11.33%$794M |
| 1.76%$33M |
| MAR +9.6pp |
No shared counterparties.